Cipla Quality as a centre of excellence assures a culture of compliance and follows systematic interventions to consistently meet or exceed quality standards.
We believe that the key to strengthening the foundation of a responsible brand lies in consistently achieving high standards of quality in everything we do. Quality is embedded at every stage of our operations, including procurement, manufacturing, delivery and safe product disposal. Our focus over the past few years has been to enhance our Quality Management Systems to meet and exceed the current expectations of regulatory authorities such as CDSCO, US FDA, MHRA, TGA, MCC and WHO.
We’re committed to achieving zero-defect and implement strict quality controls to ensure that every product released from our manufacturing facility adheres to all applicable quality and regulatory standards. This reputation of delivering consistently high- quality products has helped us to be considered as one of the partners of choice for multinational Government and Non-Government institutions globally. The Quality by Design (QbD) team and Development Quality Assurance (DQA) team work closely with the R&D function to monitor quality during clinical trials, tech transfer and developing molecules.
During the manufacturing process, the Quality Control (QC) team establishes and implements robust practices to ensure quality. Post manufacturing, this is reinforced through appropriate destruction of defective and expired products.
We have successfully overcome challenges such as growing regulatory pressures, demanding compliance requirements and stringent quality standards as a result of our robust Quality Control systems. The Company functions on a business model with a futuristic outlook that envisions the anticipated regulatory developments. This prepares us to adapt readily to the changing environment and ensure business continuity.
We understand that adequate and timely investment in strengthening our quality management protocols promise long-term benefits in terms of eliminating cost of failure, enhancing stakeholder confidence and bolstering legal compliance. We have state-of-the-art manufacturing facilities that are cGMP compliant in conformity with national and international standards. Additionally, the first phase of Laboratory Information Management System (LIMS) has been completed across all Cipla Quality Control Laboratories which significantly improve compliance in our laboratories’ data management.
Our facilities ensure quality through constant upgradation of equipment, adoption of technological advances and implementation of industry benchmarked practices. We have developed a robust system to manufacture products that adhere to stringent specifications & in-process controls subsequently leading to high product quality.